Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Maintaining momentum mid month requires steady approaches. Discover ways to keep your budget on track mid month and stay aligned with goals.
25,694 articlesEli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
NVIDIA leads the Magnificent 7 in March with a 1.7% gain through Friday, while Apple and Tesla retreat as investors r...
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
May data show rising inflation pressures even as growth slows, with renewed Middle East tensions fanning fears of sta...
New-home sales slipped in April 2026, but the broader trend remains sideways. Builders linger in a cautious stance as...
Markets are chasing a quiet AI hardware rotation. The hidden trade already just rallied 31% in a month, led by memory...
A blockbuster June lift sent crypto prediction markets to new highs as a string of sports finals and championships dr...
A Sea Limited executive sold $4.4 million in stock but remains one of the company’s biggest stakeholders. This piece ...
TD Bank has been on investors' radars, but sustained upside hinges on three core drivers. Explore how regulatory shif...
A pivotal forecast on Social Security exposes a potential 22% benefit cut if lawmakers fail to act, reshaping retirem...
Amazon isn’t only about Prime or AWS. An underrated reason to invest Amazon stock is its fast-growing advertising bus...
Investors debating IHE vs XBI face a trade-off between stability and growth. This guide breaks down how ishares pharm...